Home | MeMed
The MeMed BV Test delivers rapid bacterial vs viral differentiation in 15 minutes, empowering better treatment decisions and responsible antibiotic use.
Conheça a Memed! Soluções Digitais para Médicos e Pacientes
Conheça as soluções digitais mais inovadoras com a Memed! Prescrições Digitais, Orientações e Aquisições de Medicamentos de forma simples e rápida!
MeMed BV Bacterial Viral Immunoassay Test | Beckman Coulter
MeMed BV® is a regulatory-cleared host-immune response assay for accurately distinguishing between bacterial and viral infections within the ED workflow in just 15 minutes.
MeMed Receives FDA Breakthrough Device Designation for ...
2 days ago · NEW YORK – Infectious disease diagnostics firm MeMed said Wednesday that its MeMed BV Flex test has received Breakthrough Device Designation from the US Food and Drug …
FDA Grants Breakthrough Device Designation to MeMed's ...
2 days ago · MeMed announced that the Food and Drug Administration (FDA) has granted Breakthrough Device Designation to MeMed BV Flex, an investigational test designed to accurately …
FDA Grants Breakthrough Device Designation to MeMed BV Flex ...
2 days ago · MeMed Severity™ has received FDA Breakthrough Device Designation as a host-response test designed to predict severe outcomes up to 72 hours and mortality 14 days in advance in patients …
MeMed Wins FDA Breakthrough Status for AI-Driven Capillary ...
MeMed has secured U.S. FDA Breakthrough Device Designation for MeMed BV Flex, an AI-enabled host-response test that differentiates bacterial from viral infections using just a few drops of capillary …